Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Not Determined”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Testing effectiveness (Phase 2)Looking for participantsNCT05664893
What this trial is testing

Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS)

Who this might be right for
HER2 Negative Breast Cancer Not Immediately Operated
Centre Antoine Lacassagne 85
Testing effectiveness (Phase 2)Study completedNCT00045422
What this trial is testing

Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02624492
What this trial is testing

To Determine the Dose of BI 836826-GemOx and the Efficacy of BI 836826-GemOx Versus R-GemOx in Patients With Relapsed/Refractory DLBCL

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Boehringer Ingelheim 21
Early research (Phase 1)Study completedNCT00482521
What this trial is testing

CC-4047 in Treating Patients With Advanced Solid Tumors That Did Not Respond to Treatment

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 42
Not applicableUnknownNCT04712409
What this trial is testing

Surgical Innovation for Diabetes Treatment 2

Who this might be right for
Enteroendocrine Physiological Changes in Superobese Patients Submitted to Two Different Bariatric ProceduresDetermine Whether BPD With DS or SADI-S as Primary or Revisional Surgery is Superior Than the Other as First Choice for the SuperobeseDetermine Whether or Not Revision Surgery is as Effective as Primary Surgery and Understand the Physiological Mechanisms Inherent in These Putative Differences
Hospital de Sao Sebastiao
Not applicableStudy completedNCT00002310
What this trial is testing

SP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success With Acyclovir

Who this might be right for
Herpes SimplexHIV Infections
Shaman Pharmaceuticals
Not applicableNot Yet RecruitingNCT06797570
What this trial is testing

The Primary Objective of This Study is to Determine Whether Positively Framed Information (PFI) on Side Effects, Compared to Negatively Framed and Extensive Information (NFI) Can Reduce the Number and Severity of Reported Adverse Events Caused by ADHD Medication in Children Aged 7 to 17 Years.

Who this might be right for
Attention Deficit DisorderAttention Deficit Disorder (ADD)Attention Deficit Disorder with Hyperactivity+13 more
St. Antonius Hospital
Testing effectiveness (Phase 2)Study completedNCT02624167
What this trial is testing

Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia

Who this might be right for
Chronic Schizophrenia
Newron Pharmaceuticals SPA 90
Early research (Phase 1)Ended earlyNCT01548924
What this trial is testing

Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Centro Nacional de Investigaciones Oncologicas CARLOS III 13
Not applicableStudy completedNCT04911296
What this trial is testing

Pill Swallow Study

Who this might be right for
Not Determined
RANI Therapeutics 150
Early research (Phase 1)Looking for participantsNCT05549661
What this trial is testing

Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms

Who this might be right for
Recurrent Chronic Myelomonocytic LeukemiaRefractory Chronic Myelomonocytic LeukemiaMyelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified+3 more
Mayo Clinic 25
Testing effectiveness (Phase 2)Study completedNCT00366379
What this trial is testing

A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 127
Testing effectiveness (Phase 2)Active Not RecruitingNCT03775486
What this trial is testing

Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)

Who this might be right for
Non-small Cell Lung Cancer NSCLC
AstraZeneca 401
Early research (Phase 1)Study completedNCT06493045
What this trial is testing

First-In-Human (FIH) Trial Evaluating the Safety and Tolerability of Single and Multiple Ascending Oral Doses of IRL757 in Healthy Volunteers

Who this might be right for
Not Determined
Integrative Research Laboratories AB 82
Testing effectiveness (Phase 2)Study completedNCT03484702
What this trial is testing

Trial to Determine the Efficacy and Safety of JCAR017 in Adult Participants With Aggressive B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Celgene 113
Not applicableStudy completedNCT01837121
What this trial is testing

A Trial of Using SMS Reminder Among Diabetic Retinopathy Patients in Rural China

Who this might be right for
ComplianceDiabetic RetinopathySMS
Sun Yat-sen University 237
Large-scale testing (Phase 3)Looking for participantsNCT07184619
What this trial is testing

Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia

Who this might be right for
Treatment-resistant Schizophrenia
Newron Pharmaceuticals SPA 400
Large-scale testing (Phase 3)Study completedNCT00689936
What this trial is testing

Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 1,623
Testing effectiveness (Phase 2)Study completedNCT01610076
What this trial is testing

Code Status Video in the Intensive Care Unit: Video Assisted Patient Education

Who this might be right for
Critical Illness
Mayo Clinic 208
Not applicableStudy completedNCT05762718
What this trial is testing

Validation of a Food Frequency Questionnaire: VioScreen

Who this might be right for
Not Determined
University of Colorado, Denver 27
Load More Results
40
130